Peder Nielsen
Member of the Global Advisors Network @ Global Bio Fund
Copenhagen, Denmark
Peder Nielsen is a seed investor at Global Bio Fund in Copenhagen focused on Biotechnology. Peder Nielsen - Member of the Global Advisors Network @ Global Bio Fund
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Peder Nielsen invests in
Stages Peder Nielsen invests in
Countries Peder Nielsen invests in
Investment Focus
Stage
- Seed 1 (25%)
- Funding Round 1 (25%)
- Convertible Note 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Bactobio
|
Bactobio uses breakthrough technologies in synthetic biology, next-generation sequencing and machine learning to harvest novel microbes and screen them for medical and industrial applications.It aims to help solve the antibiotic resistance crisis by discovering novel antibiotic classes targeting some of the most urgent bacterial pathogens -before moving on to broader applications. | $7.9M / Dec 05, 2022 | |
|
Bactobio
|
Bactobio uses breakthrough technologies in synthetic biology, next-generation sequencing and machine learning to harvest novel microbes and screen them for medical and industrial applications.It aims to help solve the antibiotic resistance crisis by discovering novel antibiotic classes targeting some of the most urgent bacterial pathogens -before moving on to broader applications. | $7.9M / Dec 05, 2022 | |
|
Bactobio
|
Bactobio uses breakthrough technologies in synthetic biology, next-generation sequencing and machine learning to harvest novel microbes and screen them for medical and industrial applications.It aims to help solve the antibiotic resistance crisis by discovering novel antibiotic classes targeting some of the most urgent bacterial pathogens -before moving on to broader applications. | $7.4M / Convertible Note / Dec 01, 2022 | |
|
Bactobio
|
Bactobio uses breakthrough technologies in synthetic biology, next-generation sequencing and machine learning to harvest novel microbes and screen them for medical and industrial applications.It aims to help solve the antibiotic resistance crisis by discovering novel antibiotic classes targeting some of the most urgent bacterial pathogens -before moving on to broader applications. | $3.8M / Seed / Oct 06, 2021 |
Co-Investors
About Global Bio Fund
Bio Innovation Impact. Building the world's first seed accelerator fund for women bio entrepreneurs #XCombinator
Global Bio Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Peder Nielsen
Member of the Global Advisors Network
|
|||
Giorgio Reggiani
Founding Partner & CFO
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Peder Nielsen invest in?
Peder Nielsen invests primarily in Biotechnology startups, most often at Seed and Funding Round stage. Most of the 4 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Peder Nielsen last invest?
The most recent investment recorded for Peder Nielsen closed in Dec 2022. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
